# An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients

> **NCT05293704** · PHASE4 · UNKNOWN · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 30 (estimated)

## Conditions studied

- Kidney Transplant Recipients
- BK Virus

## Interventions

- **DRUG:** Mizoribine

## Key facts

- **NCT ID:** NCT05293704
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05293704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05293704, "An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05293704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*